Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: J Subst Abuse Treat. 2009 Mar 31;37(3):313–317. doi: 10.1016/j.jsat.2009.02.001

Table 1.

Included Studies

STUDY NAME N PATIENT POPULATION BRIEF DESCRIPTION OUTCOME
Amantadine and Propranolol(Kampman et al., 2006) AMPRO 199 Cocaine dependent, alcohol co-dependence allowed if med-free detox 10-week double-blind trial with 4 groups;
Amantadine 300 mg/day
Propranolol 100 mg/day
Amantadine + Propranolol
Placebo
No overall significant effect of either drug alone or the combination.
Among highly adherent patients, Propranolol had better retention and AB rates.
Naltrexone and Disulfiram(Pettinati et al., 2008) DISULF 208 Cocaine and alcohol dependence 14-week double-blind trial with 4 groups;
Disulfiram 250 mg/day
Naltrexone 100 mg/day
Disulfiram + Naltrexone
Placebo
Abstinence from cocaine as measured by cocaine-negative urines and days of self-reported abstinence from cocaine or alcohol did not differ between placebo and any of the medication groups
HHS Vulnerability Disclosure